Your browser doesn't support javascript.
loading
Evidence of the protective role of Carvacrol in a retinal degeneration animal model.
Inda, Ayelen; Martinez, Sofía; Bessone, Carolina; Rios, Maximiliano; Guido, Mario; Herrero-Vanrell, Rocío; Luna, Jose Domingo; Allemandi, Daniel; Ravetti, Soledad; Quinteros, Daniela.
Afiliação
  • Inda A; Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET y Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, 5000, Córdoba, Argentina; Centro de Investigación y Transferencia (CIT VM), 5900, Villa María, Córdoba, Argenti
  • Martinez S; Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET y Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, 5000, Córdoba, Argentina.
  • Bessone C; Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET y Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, 5000, Córdoba, Argentina; Departamento de Ciencias Básicas, Escuela Ciencias de la Salud, Universidad Nacional
  • Rios M; Centro de Investigaciones en Química Biológica de Córdoba (CIQUIBIC), Facultad de Ciencias Químicas, Universidad Nacional de Córdoba. 5000 Córdoba, Argentina.
  • Guido M; Centro de Investigaciones en Química Biológica de Córdoba (CIQUIBIC), Facultad de Ciencias Químicas, Universidad Nacional de Córdoba. 5000 Córdoba, Argentina.
  • Herrero-Vanrell R; Grupo de Investigación en Innovación, Terapia y Desarrollo Farmacéutico en Oftalmología (UCM 920415), Departamento de Farmacia y Tecnología de Alimentos, Facultad de Farmacia. Universidad Complutense, 28040, Madrid, Spain.
  • Luna JD; Área de Cirugía Vítreo y Retina, Centro Privado de Ojos Romagosa S.A. y Fundación VER, 5000, Córdoba, Argentina.
  • Allemandi D; Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET y Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, 5000, Córdoba, Argentina.
  • Ravetti S; Centro de Investigación y Transferencia (CIT VM), 5900, Villa María, Córdoba, Argentina; Instituto Académico Pedagógico de Ciencias Humanas, Universidad Nacional de Villa María, 5900, Villa María, Córdoba, Argentina.
  • Quinteros D; Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET y Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, 5000, Córdoba, Argentina. Electronic address: danielaquinteros@unc.edu.ar.
Exp Eye Res ; 244: 109938, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38789020
ABSTRACT
Neurodegenerative pathologies affecting the posterior segment of the eye, are characterized by being devastating and responsible for the majority of visual dysfunctions worldwide. These diseases are primarily degenerative, progressing chronically, and can inflict gradual harm to the optic nerve, retinal ganglion cells (RGC), photoreceptors, and other retinal cells. This retinal damage leads to a progressive loss of vision, marking these conditions as a significant health concern worldwide. The intravitreal administration of the phytochemical Carvacrol (CAR) is expected to demonstrate a neuroprotective and antiapoptotic effect on retinal cells, with a specific focus on RGC. This effect will be observed in a retinal degeneration model (RDM) in rabbits induced by cytotoxic and oxidative agents, namely glutamate (GLUT) and L-buthionine-S, R-sulfoximine (BSO). An in vivo study was conducted using New Zealand rabbits in which retinal damage was created to evaluate the effectiveness of CAR. The effectiveness of CAR on the functionality of retinal neuronal cells in RDM was evaluated using pupillary light reflection (PLR). Furthermore, the phytotherapeutic's influence on cell viability was determined through flow cytometry analysis. Finally, the neuroprotective and antiapoptotic capabilities of CAR were specifically scrutinized in RGC through histological studies, quantifying cell survival, and employing immunohistochemical assays to detect the apoptotic index (%) using the TUNEL technique. Our results demonstrated that CAR promoted the recovery of the pupillary contraction profile over time, maintaining the functionality of retinal cells as healthy controls. Additionally, it showed increased cell viability under oxidative and cytotoxic conditions given by GLUT-BSO agents. Finally, we found that CAR protects the survival of RGC and decreases the percentage of apoptotic cells when compared to RDM. CAR demonstrated to have positive effects on the functionality of photoreceptive nerve cells by restoring pupillary contraction. Likewise, it was shown to have neuroprotective and antiapoptotic effects when evaluated in a general and specific way on retinal nerve cells.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Degeneração Retiniana / Células Ganglionares da Retina / Sobrevivência Celular / Modelos Animais de Doenças / Cimenos Limite: Animals Idioma: En Revista: Exp Eye Res Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Degeneração Retiniana / Células Ganglionares da Retina / Sobrevivência Celular / Modelos Animais de Doenças / Cimenos Limite: Animals Idioma: En Revista: Exp Eye Res Ano de publicação: 2024 Tipo de documento: Article
...